FIELD: oncology.
SUBSTANCE: treatment consists in performing 2-4 courses of preoperative chemotherapy with 2-weak intervals between courses, each course comprising intravenous administration of methotrexate in dose 40 mg/m2 on first or eighth day and intramuscular cyclophosphanin dose 100 mg/m2 during 14 days, while introducing additionally oral Xeloda in dose 1000 mg/m2 twice a day on the first to fourteenth days.
EFFECT: achieved complete regression of tumor focus owing to high selectivity of Xeloda preparation diminishing toxic effect of chemotherapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OPERABLE BREAST CANCER MEDICAL TREATMENT | 2006 |
|
RU2325914C2 |
METHOD FOR TREATING PATIENTS POSSESSING DIFFUSE FORMS OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2133607C1 |
METHOD FOR TREATING THE CASES OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2134111C1 |
METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
METHOD FOR TREATING CANCER OF UTERINE BODY | 2000 |
|
RU2195268C2 |
METHOD FOR TREATING LOCALLY GENERALIZED CANCER OF THE MAMMARY GLAND WITH TUMOR-INDUCED SKIN ULCERS | 2001 |
|
RU2176922C1 |
METHOD OF TREATMENT OF LOCALLY ADVANCED BREAST CANCER | 2007 |
|
RU2348419C2 |
METHOD OF TREATMENT OF MAMMA CANCER | 1994 |
|
RU2092160C1 |
METHOD OF TREATING BREAST CANCER | 2011 |
|
RU2465924C2 |
METHOD OF TREATMENT OF PATIENTS WITH DISSEMINATED FORMS OF BREAST CANCER | 1996 |
|
RU2131734C1 |
Authors
Dates
2006-12-10—Published
2004-10-05—Filed